- Humana is down ~3% in Wednesday morning trading despite raising fiscal 2022 adjusted EPS guidance and Q2 results that beat on the top and bottom lines .
- Full-year adjusted EPS guidance of "approximately $24.75" tops the consensus estimate of $24.66. That figure, if it holds up, would be a 20% increase over FY 2021.
- Humana said it is benefitting from lower utilization than expected and no headwinds from COVID-19 in its core Medicare Advantage segment.
- Net income in the quarter of $696M was ~18% increase from the year-ago period.
- Revenue of ~$23.7B was ~15% increase from Q2 2021.
- Humana ended the quarter with ~$5.2B in cash and cash equivalents, an increase of ~52% from Dec. 31, 2021.
- Humana ( NYSE: HUM ) is the top-rated managed care stock according to Seeking Alpha's Quant rating.
For further details see:
Humana down 3% despite raising 2022 EPS guidance and Q2 top and bottom line beats